SCOPUS 정보 검색 플랫폼

Volumn 87, Issue 6, 2009, Pages 685-687

Rapid progression of subclinical age-related macular degeneration in the untreated fellow eye after intravitreal bevacizumab

(4) Yoon, Young Hee a Kim, June Gone a Chung, Hyewon a Lee, Sun Young a

a University of Ulsan College of Medicine (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

AGED; ANAMNESIS; CASE REPORT; DISEASE COURSE; DRUSEN; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; LETTER; MALE; METAMORPHOSIS; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; DISEASE PROGRESSION; FEMALE; HUMANS; INJECTIONS; MACULAR DEGENERATION; MALE; TIME FACTORS; VITREOUS BODY;

EID: 69449104924 PISSN: 1755375X EISSN: None Source Type: Journal
DOI: 10.1111/j.1755-3768.2008.01281.x Document Type: Letter

Times cited : (7)

References (7)

1
- 33748982649
- Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy
- Avery RL, Pearlman J, Pieramici DJ et al. (2006 Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113 : 1695. e1-15.
- (2006) Ophthalmology , vol.113 , Issue.1695
- Avery, R.L.¹ Pearlman, J.² Pieramici, D.J.³

2
- 34247400587
- Pharmacokinetics of intravitreal bevacizumab (Avastin)
- Bakri SJ, Snyder MR, Reid JM, Pulido JS Singh RJ (2007 Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 114 : 855 859.
- (2007) Ophthalmology , vol.114 , pp. 855-859
- Bakri, S.J.¹ Snyder, M.R.² Reid, J.M.³ Pulido, J.S.⁴ Singh, R.J.⁵

3
- 36549016602
- Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab
- Brantley MA Jr., Fang AM, King JM, Tewari A, Kymes SM Shiels A (2007 Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab. Ophthalmology 114 : 2168 2173.
- (2007) Ophthalmology , vol.114 , pp. 2168-2173
- Brantley Jr., M.A.¹ Fang, A.M.² King, J.M.³ Tewari, A.⁴ Kymes, S.M.⁵ Shiels, A.⁶

4
- 38049160197
- Bevacizumab (Avastin) does not harm retinal function after intravitreal injection as shown by electroretinography in adult mice
- Heiduschka P, Julien S, Hofmeister S, Bartz-Schmidt KU Schraermeyer U (2008 Bevacizumab (Avastin) does not harm retinal function after intravitreal injection as shown by electroretinography in adult mice. Retina 28 : 46 55.
- (2008) Retina , vol.28 , pp. 46-55
- Heiduschka, P.¹ Julien, S.² Hofmeister, S.³ Bartz-Schmidt, K.U.⁴ Schraermeyer, U.⁵

5
- 34547804337
- Acute retinal pigment epithelial tear in the untreated fellow eye following repeated bevacizumab (Avastin™) injections
- Mennel S, Callizo J, Schmidt JC Meyer CH (2007 Acute retinal pigment epithelial tear in the untreated fellow eye following repeated bevacizumab (Avastin™) injections. Acta Ophthalmol Scand 85 : 689 691.
- (2007) Acta Ophthalmol Scand , vol.85 , pp. 689-691
- Mennel, S.¹ Callizo, J.² Schmidt, J.C.³ Meyer, C.H.⁴

6
- 47649125703
- Complications in patients after intravitreal injection of bevacizumab
- Shima C, Sakaguchi H, Gomi F et al. (2008 Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol 86 : 372 376.
- (2008) Acta Ophthalmol , vol.86 , pp. 372-376
- Shima, C.¹ Sakaguchi, H.² Gomi, F.³

7
- 33645028105
- Contribution of VEGF and PEDF to choroidal angiogenesis: A need for balanced expressions
- Tong JP Yao YF (2006 Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions. Clin Biochem 39 : 267 276.
- (2006) Clin Biochem , vol.39 , pp. 267-276
- Tong, J.P.¹ Yao, Y.F.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.